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Iodine as a cause of thrombocytopenia is not listed in 
hematology textbooks. A Medline search over the past 10 
years reveals no such occurrence. In this report a patient 
exposed to iodine developed profound thrombocytopenia. 
Case Report 
A 24-year-old Samoan-Chinese man who was a dairy 
worker developed bruises and petechiae. When seen 3 days 
later, other than the hemorrhagic skin findings, no other 
physical abnormalities were found. A CBC revealed WBC 
12,400/cmm, RBC 4.66 million/cmm, hemoglobin 14.3 
grams, MCV 89, MCH 30.6, MCHC 34.6. The differential 
smear showed segs 88, band l, lymphs 7, monocytes 4%. 
The platelet count was markedly depressed at 8000/cmm and 
the reticulocyte count was 1%. ANA, RA factor, and serum 
protein electrophoresis were all normal. Total serum iodine 
was 9.8 ug/dL (normal4.5-10.0). 
Bone marrow examination revealed marked megakary-
ocytic hyperplasia. 
For the previous 2 to 3 months he had been spraying dairy 
cows' udder teats with Teat Dip, a glycerin-iodine solution con-
taining 0.1% iodine, as a prophylactic against mastitis. The patient 
was advised to discontinue all further use of Teat Dip spray. 
Prednisone 80 mg a day P.O. was started and 10 units of 
platelets were given for nose bleed on day 7. Two days later, 
the platelet count had risen to 25,000/cmm, but dropped 
sharply to 11 ,000/cmm by day 11. Therefore, danazol 600 
mg/day was added on day 12 for a greater immuno-suppres-
sive effect because it was apparent that prednisone in the 
dose given was not effective. Because of the decreasing 
platelet count and the severity of the thrombocytopenia, 
splenic radiation also was started on day 12 at a dose of one 
Gy. Thereafter, 6 biweekly fractions were given for a total of 
6 Gy over a 3-week period. Six and a half weeks after onset 
of the disease the platelet count again was severely reduced 
to 3000/cmm and the dose of danazol, therefore, was 
increased to 800 mg/day. Vincristine 2 mg i.v. and gamma 
globulin 25 grams i.v. also were given. 
Prosorba immunoabsorption resin column therapy initiat-
ed a month earlier and 6 daily column treatments were given 
because of the decreasing platelet count and high risk for 
clinical bleeding, especially in the brain in a young person. 
The platelet count had risen rapidly to 70,000/cmm as a result, 
but then dropped to 40,000/cmm a week later. It finally rose to 
436,000/cmm at 2 months post-onset and remained normal. 
The platelet count was 415,000/cmm at 7 months. 
Prednisone was gradually reduced and had been discontinued 
at 2 months, the danazol was discontinued at the same time. 
Throughout his entire illness, the patient was treated as an 
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outpatient. The return of his platelet count to normal took 27 
days (platelet count of 160,000/cmm). 
Other than the exposure to iodine, no other causes for the 
thrombocytopenia could be elicited. Which modality of the 
multiple therapies was the most effective could not be deter-
mined, and in all probability, all of the combined therapies 
contributed to his recovery. 
Discussion 
Although there is no direct proof that iodine spray used to 
treat the dairy cows' udders had caused thrombocytopenia, in 
this case a causal relationship is strongly suspected. To 
expose this patient to the iodine again in order to attempt to 
re-induce the thrombocytopenia to prove a direct cause and 
effect was unwise and highly risky. 
Isolated thrombocytopenia caused by iodine or iodides has 
not been reported in the recent past. Preparations of iodine and 
iodides include Lugol's solution (iodine), sodium and potassi-
um iodide solutions, expectorants containing sodium or potas-
sium iodide, radioactive iodine (sodium iodide L-131); antisep-
tics, such as Betadine, containing povidone-iodine in the form 
of ointments, solutions, skin cleansers, surgical scrubs and 
vaginal suppositories; and x-ray-contrast material also contains 
iodine. Teat Dip contains free iodine mixed with glycerin. 
The adverse effects of iodine and iodides include chronic 
iodine and iodide intoxication (iodism), usually dose related, 
such as unpleasant taste (described as brassy), burning in the 
mouth, sore mouth and throat, hypersalivation, painful 
sialadenitis, acne, rash, productive cough, diarrhea, coryza, 
sneezing, upset gastric irritation, weakness, foul breath, fever, 
depression, and occasionally goiter if large doses are given for 
long periods. In the treatment of nontoxic nodular goiter, 
administration of iodine can increase plasma thyroid hormone 
and cause thyrotoxic symptoms. Adverse effects of the topical 
and vaginal iodine-containing ointments and solutions include 
local redness, irritation, swelling, pain and burning. 
Individuals occasionally are very sensitive to iodine or to 
organic preparations containing iodine, especially when 
given i.v. Acute reactions can occur almost immediately or 
can occur several hours after administration. Angio-edema of 
the larynx leading to dyspnea and suffocation can occur; skin 
hemorrhages, serum sickness manifestations such as fever, 
arthralgia, lymph-node enlargement, and eosinophilia could 
occur. Thrombotic thrombocytopenic purpura and fatal peri-
arteritis nodosa have been described2• 
Individuals who are sensitive to iodine or iodide by any 
route should be cautioned against its use. 
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